Welcome to the Company Profile of Medinvents, the global leader of innovative products for minimal invasive biopsy. We provide a complete suite of biopsy devices needed to support healthcare providers in giving the best care to their patients. Our products provide a minimal invasive large core soft tissue biopsy with the highest level of accuracy and safety. Resulting in a fast and easy procedure with optimal diagnosis and better patient treatment. The need for better tissue acquisition in the early detection of cancer has been recognized for a long time. In 2004 this led to the foundation of Medinvents based on years of R&D by an international group of physicians and health care providers that requested novel tools. Since 2005, the company creates instruments that were never built before and that are based on new and innovative concepts. In particular, the direct and frontal targeting and full core samples are explored in every detail resulting in affordable, safe and high quality large core biopsies that would give every woman access to an early and reliable detection of breast cancer. The devices are manufactured according to the highest integral quality control regulations covered by ISO 9001-2000 and ISO 13485 since 2006. In 2007, the range of biopsy instruments covers almost all soft tissues of the human body like soft tissues in bony structures, gynecological applications, and tools for anatomical regions that were not accessible before. The materials are exquisite and comply with every imaging technique. All products underwent intensive clinical testing and are fully CE and FDA approved since 2008. An increasing number of physicians with interventional experience find the services Medinvents an essential addition to their routine clinical practice. The 2008 award winning company has several new options in the research portfolio. All these efforts serve just one mission: to save more cancer patients without compromising comfort.